Search results for: Adrian Towse
Filter search results
Evidence on Valued Based Pricing and Reimbursement Schemes
30 September 2011
…for pharmaceuticals. In particular, a better understanding is needed about whether and how transaction costs may affect the implementation of the schemes. Download Puig-Pieró, R., Merstre-Ferrandiz, J., Sussex, J. and Towse,…
New: Pay-for-Performance for Drugs and Incentives for Innovation
27 February 2012
…schemes, providing examples; discuss the benefits and weaknesses of such schemes; and consider their value as an incentive for innovation. Download Towse, A., Garrison, L. and Puig-Peiró, R. The use…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…at launch, review would be by a diagnostics-dedicated committee using VBP principles. Download Garau, M., Towse, A., Garrison, L., Housman L. and Ossa, D. Can and should value based pricing…
Spotlight on OHE: Recent Awards, Publications and Presentations
12 September 2012
…Valuing health at the end of life: An exploratory preference elicitation study. OHE Research Paper 11/06. London: Office of Health Economics. [2] Puig-Peiró, R., Mestre-Ferrandiz, J., MacDonald, F. and Towse,…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…use. These are essential both to encouraging R&D and ensuring that patients have the earliest access possible to life-changing therapies’. Contact: Jorge Mestre-Ferrandiz Download Mestre-Ferrandiz, J., Sussex, J. and Towse,…
R&D Cost Drivers to be Explained by OHE Expert
18 January 2013
…UCL at +44 (0)20 7679 4411 . Read the recent report: download Mestre-Ferrandiz, J., Sussex, J. and Towse, A. (2012) The R&D Cost of a New Medicine. London: Office of Health Economics….
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
…HTA agencies sometimes reach different conclusions about the same medicines. The authors discuss possible reasons for these differences and offer recommendations for improving HTA processes. Shah, K.K., Mestre-Ferrandiz, J., Towse,…
Valuing Co-Dependent Medical Technologies: Improving Methods and Processes
23 April 2013
…information, please contact Martina Garau. See also: Garau, M., Towse, A., Garrison, L., Housman, L. and Ossa, D. (2012) Can and should value based pricing be applied to molecular diagnostics?…
Exploring the Link Between Health and Wealth in Government Decision Making
16 May 2013
…to address the barriers identified in order to ensure efficient priority setting within health and across public sectors. Download: Garau, M., Shah, K., Sharma, P. and Towse, A. (2013) Is…